Anti-Drug Antibody Solution

Gyros Protein Technologies

Gyrolab ADAThe Gyrolab™ anti-drug antibody (ADA) solution provides a nanoliter-scale method for automated acid pretreatment in a Gyrolab Mixing CD with 96 microstructures. The solution enables users to automatically run drug-tolerant ADA assays in a time-efficient way with small volvolumes of patient samples and reagents—reducing hands-on time and shortening run times. The Gyrolab ADA protocol and dedicated analysis software, designed for 21 CFR Part 11 compliance, streamlines workflows from assay development through to screening and confirmation. The assays exhibit high drug tolerance and deliver sensitivity and consistent performance, providing quality data.